Publication dates

Gastric Cancer Industry, January 2015 Market Reports from Top Publishers

You might be interested in: cancer, colorectal cancer, biosimilar, breast cancer.


 
1-10 of 28 reports for Gastric Cancer

Acuvax Ltd (Symbol:ACU) SWOT Analysis, Strategy, Revenues and Profits

Acuvax Ltd (Symbol:ACU) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Acuvax ltd (acu) - financial and strategic swot analysis review summaryacuvax ltd (acuvax) is a healthcare service provider. The organization develops vaccine for breast and gastric ...

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Natural human antibody-based therapeutic products for the treatment of cancer and many other diseases. Its product pipeline includes pat-sc1 used for the treatment of gastric cancer; pat-sm6, pat-pa1 ...

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Also provides virotherapy technology that uses group of viruses to target cancer cells. It conducts cancer research on gastric cancer with evatak, ovarian cancer with evatak, and melanoma studies ...

Ascenion GmbH - Product Pipeline Analysis, 2014 Update

Ascenion GmbH - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Colorectal cancer 23biomarker test - colorectal cancer product overview 23biomarker test - gastric cancer 24biomarker test - gastric cancer product overview 24biomarker test - residual ...

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... And services 13exploit technologies pte ltd number of pipeline products by development stage 14exploit technologies pte ltd pipeline products summary by development stage 15biomarker - gastric ...

Array BioPharma Inc. (Symbol:ARRY) SWOT Analysis, Strategy, Revenues and Profits

Array BioPharma Inc. (Symbol:ARRY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2014
  • by Global Data

... And loxo-101, which are indicated for cancer; arry-543/aslan001 being developed for the treatment of gastric cancer; danoprevir and arry-382/ont-380 being developed for hepatitis c virus infections ...

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

... For the treatment of gastric cancer in japan in 1999.The drug subsequently gained japanese approval for colorectal cancer in 2003, and is also approved for other indications, including nsclc and breast cancer ...

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

... Oncology indications, including breast cancer, gastric cancer, hcc, and nsclc. A phase iii study (raise) is investigating ramucirumab as a treatment for second-line metastatic crc patients who have ...

Cancer Research UK SWOT Analysis, Strategy, Revenues and Profits

Cancer Research UK SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Diagnosis, detection and prognosis; prevention; and treatment. Cruk provides treatment for various types of cancer such as anal cancer, bladder cancer, bowel cancer, cervical cancer, eye cancer, gastric ...

Gastric Cancer - Pipeline Review, H2 2014

Gastric Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of gastric cancer- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

About 400 reports for Gastric Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Taiwan

  • September 2014
    9 pages
  • Pathology  

    Gastric Cancer  

  • Taiwan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.